A number-needed-to-treat analysis of the use of respiratory syncytial virus immune globulin to prevent hospitalization.
Open Access
- 1 April 1998
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Pediatrics & Adolescent Medicine
- Vol. 152 (4), 358-366
- https://doi.org/10.1001/archpedi.152.4.358
Abstract
To estimate how many infants in selected high-risk subgroups would require treatment with respiratory syncytial virus immune globulin (RSV-IG) to avoid 1 hospital admission and to determine whether this is economically justified.Keywords
This publication has 1 reference indexed in Scilit:
- Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young childrenThe Journal of Pediatrics, 1994